Hawley Presses FDA Nominee About Mifepristone: Should There Be An ‘In-Person Dispensing’ Protocol?

12 hours ago
77

3/06/2025

During Thursday’s Senate Health, Education, Labor, and Pension Committee hearing, Sen. Josh Hawley (R-MO) questioned Trump’s FDA Commissioner Nominee Martin Makary about Mifepristone requirements.

Loading comments...